Recent News

Tradable Bottom In With Biotech But Don’t Go Crazy

Large Caps Are Recovering But Follow Q1 Earnings Closely Fidelity Select Biotech FBIOX( $176 ) must hold $172 for new buys. Healthcare sector XLV ($56.94)  lagging industrials and energy. April 15 Low Must Hold IBB ($207.70) Our top picks that are off 5 day bottom and higher: ABBV ALKS ALXN, BIIB, GILD. Even laggard Celgene […]

Continue Reading →

No Confirmed Trading Bottom In Biotech Yet: Biotech ETF Review..Update-1

Update at Close 4/15….. Late Day Reversal To Green The NASDAQ Composite began a rally at 1P EDT and never stopped , moving up 62 points to close at 4034. Biotech ETFs followed step by step to end up in the green after a severe daily decline. The IBB ($217.6) ended up 1% after hitting […]

Continue Reading →

Biotech Rout Not Surprising: Surveying The Damage

Top Ten Reasons For Biotech Correction NASDAQ at 4022,IBB at 221 A Sentiment Driven Market We have been writing about the bull market in biotech stocks since its inception in March 2009 when quality companies were advancing their pipelines and new products in immunology, oncology and infectious disease were being launched. The life science sector […]

Continue Reading →

Risk Reversal: Bargain Hunting and FOMC Catalyst Perks Up Biotech Stocks… Update-1

Update 4/10 Abrupt Sell-Off –Failure to Confirm Bottom NASDAQ down 71 pts 1.7% All of yesterdays’ gains wiped out and we are back to January levels. Raise cash levels to 30% on life science portfolios.  Many high fliers and core holdings are selling off today after bullish action yesterday. See ALXN,GILD, IBB, ILMN, INCY,MDVN, PCYC, […]

Continue Reading →

Seeking A Technical Bottom For Biotech Stocks….. Update 4/9 Rally

NASDAQ Up 0.37% to 4133 Green screen alert with large cap biotechs. Time to cover hedges. Alexion (ALXN) up 2.23% Biogen (BIIB) Up 2.4% Celgene (CELG) up 3.61% Clovis Oncology (CLVS) up 2.85% Gilead (GILD) up 1.35% IBB up 1.96% Regeneron (REGN) up 3.99% Key Trends To Watch: April Update After Correction We provided a […]

Continue Reading →

Rayno Life Science: Tools and Diagnostics Q1 2014 Performance

Caution As Life Science Stocks Are Consolidating Life science stocks had a wild roller coaster ride in 2014 with many stocks peaking around March 1. Momentum and cult stocks in our portfolio still had a good quarter with the following top winners: Illumina (ILMN) up 25.2%, Vermillion (VRML) up 25%, Exact Sciences (EXAS) up 21% […]

Continue Reading →